Thomas F. Whayne Jr., MD, PhD

Practice areas

Practice areas

Clinical interests

  • Cardiovascular Disease
  • Cardiovascular Risk Reduction
  • Lipid Management

Thomas F. Whayne Jr., MD, PhD

Biography

My name is Thomas Whayne; I received my medical degree from the University of Pennsylvania, School of Medicine, Philadelphia. I then completed fellowships at the University of California at San Francisco Medical Center and the University of Toronto Medical Center in Canada.

I am board certified by the American Board of Internal Medicine in Cardiovascular Disease.

Faculty rank

Professor of Medicine

Education

Degree
University of Pennsylvania, School of Medicine, Philadelphia

Residency
New York Hospital-Cornell Medical Center

Fellowship
University of California at San Francisco Medical Center
University of Toronto Medical Center, Toronto, Canada

Certifications or Special training
American Board of Internal Medicine
American Board of Internal Medicine, Cardiovascular Disease

Cardiovascular Medicine

UK Albert B. Chandler Hospital - Pavilion G
Gill Heart Institute
First Floor
1000 S. Limestone
Lexington KY 40536-0602


UK HealthCare accepts many forms of insurance. See list of insurers »

 
  1. Whayne TF, Mukherjee D.
    Increased Exercise Favorably Modifies Coronary Artery Disease and Peripheral Arterial Disease Outcomes.
    Curr Vasc Pharmacol. 2016 Jul 22.
  2. Whayne TF, Saha SP, Mukherjee D.
    Antioxidants in the Practice of Medicine; What Should the Clinician Know?
    Cardiovasc Hematol Disord Drug Targets. 2016 Jun 13.
  3. Whayne TF.
    Multiple Coronary Artery Interventions.
    Angiology. 2016 May;67(5):427-30.
  4. Whayne TF.
    Defining the Role of PCSK9 Inhibitors in the Treatment of Hyperlipidemia.
    Am J Cardiovasc Drugs. 2016 Apr;16(2):83-92.
  5. Whayne TF. Statin Intolerance From a Clinician's Perspective. Angiology. 2016 Mar;67(3):205-7.
  6. Whayne TF, Maulik N. Nutrition and the healthy heart with an exercise boost. Can J Physiol Pharmacol. 2012 Aug; 90(8):967-76. PMID: 22812658.
    View in: PubMed
  7. Whayne TF. Atherosclerosis: current status of prevention and treatment. Int J Angiol. 2011 Dec; 20(4):213-22. PMID: 23204822.
    View in: PubMed
  8. Saha SP, Whayne TF, Mukherjee DP. Current management of peripheral vascular disease: where is the evidence? Cardiovasc Hematol Agents Med Chem. 2011 Apr 1; 9(2):128-36. PMID: 21434864.
    View in: PubMed
  9. Whayne TF. Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators. Angiology. 2011 Jul; 62(5):415-21. PMID: 21421631.
    View in: PubMed
  10. Whayne TF. [Problems with statins and the marketing of these medications]. Rev Med Chil. 2010 Apr; 138(4):511-4. PMID: 20668802.
    View in: PubMed
  11. Whayne TF. What should medical practitioners know about the role of alternative medicines in cardiovascular disease management? Cardiovasc Ther. 2010 Apr; 28(2):106-23. PMID: 20398100.
    View in: PubMed
  12. Salters CR, Bailey AL, Whayne TF. Current treatment of heart failure in the USA. Expert Rev Cardiovasc Ther. 2010 Feb; 8(2):279-90. PMID: 20136614.
    View in: PubMed
  13. Whayne TF. Concerns about heparin therapy for hypertriglyceridemia. Arch Intern Med. 2010 Jan 11; 170(1):108-9; author reply 109. PMID: 20065209.
    View in: PubMed
  14. Whayne TF. Metabolic syndrome, peripheral vascular disease and coronary artery disease: A concise review. Int J Angiol. 2010; 19(3):e96-9. PMID: 22477621.
    View in: PubMed
  15. Saha SP, Whayne TF, Mukherjee D. Evidence-based management of carotid artery disease. Int J Angiol. 2010; 19(1):e21-4. PMID: 22477570.
    View in: PubMed
  16. Saha SP, Whayne TF. Cardiovascular care: a challenge for Kentucky. J Ky Med Assoc. 2009 Aug; 107(8):295-7. PMID: 19777939.
    View in: PubMed
  17. Whayne TF. In defense of the metabolic syndrome. J Clin Lipidol. 2009 Aug; 3(4):247-9. PMID: 21291820.
    View in: PubMed
  18. Whayne TF. High-density lipoprotein cholesterol: current perspective for clinicians. Angiology. 2009 Oct-Nov; 60(5):644-9. PMID: 19240106.
    View in: PubMed
  19. Abascal VM, Zielke JC, Spady SD, Mason JW, Whayne TF. Synopsis of an epidemiologic study of a Kentucky county in the Coronary Valley. J Ky Med Assoc. 2008 Nov; 106(11):527-31. PMID: 19058478.
    View in: PubMed
  20. Whayne TF. Is there a problem with ezetimibe or just ENHANCEd hype? Angiology. 2008 Dec-2009 Jan; 59(6):661-3. PMID: 18796445.
    View in: PubMed
  21. Whayne TF. Nonprescription statins: not ready for prime time. Am J Cardiol. 2008 Mar 1; 101(5):745-6; author reply 746. PMID: 18308034.
    View in: PubMed
  22. Whayne TF. A viewpoint on statin effects - benefits and problems. Int J Angiol. 2008; 17(4):178-80. PMID: 22477445.
    View in: PubMed
  23. Whayne TF. Evaluation critique of state of the art dyslipidemia management in general and with a special emphasis on the Indian population. Indian Heart J. 2007 May-Jun; 59(3):218-25. PMID: 19124929.
    View in: PubMed
  24. Saha SP, Bhalla DK, Whayne TF, Gairola C. Cigarette smoke and adverse health effects: An overview of research trends and future needs. Int J Angiol. 2007; 16(3):77-83. PMID: 22477297.
    View in: PubMed
  25. Whayne TF. Coronary atherosclerosis, low-density lipoproteins and markers of thrombosis, inflammation and endothelial dysfunction. Int J Angiol. 2007; 16(1):12-6. PMID: 22477242.
    View in: PubMed
  26. Whayne TF, Zielke JC, Dickson LG, Winters JL. State of the art treatment of the most difficult low density lipoprotein (LDL) cholesterol problems: LDL apheresis. J Ky Med Assoc. 2002 Dec; 100(12):535-8. PMID: 12522946.
    View in: PubMed
  27. Whayne TF, Zielke JC. Problems with the new Adult Treatment Panel III guidelines. Prev Cardiol. 2002; 5(2):91. PMID: 11986555.
    View in: PubMed
  28. Whayne TF, Zielke JC. Triglyceride level: a predictive risk factor for atherosclerosis? Arch Intern Med. 2001 Jan 22; 161(2):295-6. PMID: 11176752.
    View in: PubMed
  29. Whayne TF, Zielke JC. Reduction of cholesterol in Kentucky--a state at high risk. J Ky Med Assoc. 2000 Jun; 98(6):248-53. PMID: 10870339.
    View in: PubMed
  30. Whayne TF, Alaupovic P, Curry MD, Lee ET, Anderson PS, Schechter E. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Atherosclerosis. 1981 Jun; 39(3):411-24. PMID: 6942843.
    View in: PubMed
  31. Imaizumi T, Chandraratna PA, Whayne TF, Schechter E, Bhatia SK. Transmural myocardial infarction with the prolapsing mitral-leaflet syndrome and normal coronary arteries. Arch Intern Med. 1978 Sep; 138(9):1354-5. PMID: 686924.
    View in: PubMed
  32. Leier CV, Schaal SF, Leighton RF, Whayne TF. Heart block in alcoholic cardiomyopathy. Arch Intern Med. 1974 Oct; 134(4):766-8. PMID: 4413642.
    View in: PubMed
  33. Whayne TF, Witiak DT. A comparative study of the inhibitory activity of clofibrate and related an alogs on lipoprotein lipase in vitro. J Med Chem. 1973 Mar; 16(3):228-31. PMID: 4733102.
    View in: PubMed
  34. Whayne TF, Smith NT, Eger EI, Stoelting RK, Whitcher CE. Reflex cardiovascular responses to simulated diving. Angiology. 1972 Sep; 23(8):500-8. PMID: 5055664.
    View in: PubMed